Hospital General Universitario de Elche -ko ikertzaileekin lankidetzan egindako argitalpenak (8)

2023

  1. A genetic profiling guideline to support diagnosis and clinical management of lymphomas

    Clinical and Translational Oncology

2022

  1. External Validity of Somatostatin Analogs Trials in Advanced Neuroendocrine Neoplasms: The GETNE-TRASGU Study

    Neuroendocrinology, Vol. 112, Núm. 1, pp. 88-100

2019

  1. Efficacy of the combination of rituximab-bendamustine as a second-line treatment in patients with follicular lymphoma who progress after immunochemotherapy: a phase II trial of the Spanish Lymphoma Oncology Group

    Leukemia and Lymphoma

  2. Prediction of Progression-Free Survival in Patients With Advanced, Well-Differentiated, Neuroendocrine Tumors Being Treated With a Somatostatin Analog: The GETNE-TRASGU Study

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 37, Núm. 28, pp. 2571-2580

2017

  1. Primary Breast Lymphoma: Analysis of 55 Cases of the Spanish Lymphoma Oncology Group

    Clinical Lymphoma, Myeloma and Leukemia, Vol. 17, Núm. 3, pp. 186-191

  2. Prognostic value of event-free survival at 12 and 24 months and long-term mortality for non-Hodgkin follicular lymphoma patients: A study report from the Spanish Lymphoma Oncology Group

    Cancer, Vol. 123, Núm. 19, pp. 3709-3716

2015

  1. SEOM clinical guidelines for the treatment of Hodgkin’s lymphoma

    Clinical and Translational Oncology, Vol. 17, Núm. 12, pp. 1005-1013

  2. SEOM clinical guidelines for the treatment of follicular non-Hodgkin’s lymphoma

    Clinical and Translational Oncology, Vol. 17, Núm. 12, pp. 1014-1019